×
About 116,870 results

ALLMedicine™ Multiple Sclerosis Center

Research & Reviews  54,009 results

Quality of life in multiple sclerosis is dominated by fatigue, disability and self-effi...
https://doi.org/10.1016/j.jns.2021.117437
Journal of the Neurological Sciences; Young CA, Mills R et. al.

May 15th, 2021 - Quality of life in multiple sclerosis (MS) reflects complex relationships between symptoms (fatigue, spasticity pain, and bladder or vision dysfunction), disability, health perceptions, and self-efficacy. In this cross-sectional study, a self-repo...

Identification of differential DNA methylation associated with multiple sclerosis: A fa...
https://doi.org/10.1016/j.jneuroim.2021.577600
Journal of Neuroimmunology; Garcia-Manteiga JM, Clarelli F et. al.

May 15th, 2021 - Multiple Sclerosis (MS) is caused by a still unknown interplay between genetic and environmental factors. Epigenetics, including DNA methylation, represents a model for environmental factors to influence MS risk. Twenty-six affected and 26 unaffec...

Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis.
https://doi.org/10.1097/WCO.0000000000000960
Current Opinion in Neurology; Hartung HP, Meuth SG et. al.

May 14th, 2021 - To assess the reasons for considering discontinuation of disease-modifying therapies (DMTs)in patients with multiple sclerosis (MS). Relevant aspects of the natural history, pathology, and immunology are analyzed. A number of retrospective observa...

Social cognition and executive functioning in multiple sclerosis: A cluster-analytic ap...
https://doi.org/10.1111/jnp.12248
Journal of Neuropsychology; Henry A, Lannoy S et. al.

May 14th, 2021 - Multiple sclerosis (MS) is associated with deficits in social cognition, the process underlying social interaction and cognitive function. However, the relationships between executive impairment and social cognition remain unclear in MS. Previous ...

Antinociceptive profile of ARN19702 (2-ethylsulfonylphenyl)-(2S)-4-(6-fluoro-1,3-benzot...
https://doi.org/10.1124/jpet.121.000674
The Journal of Pharmacology and Experimental Therapeutics; Fotio Y, Sasso O et. al.

May 14th, 2021 - N-acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase that stops the physiological actions of palmitoylethanolamide (PEA), an endogenous lipid messenger that activates the transcription factor, peroxisome proliferator-activate...

see more →

Guidelines  109 results

Serum neurofilament light as a biomarker in progressive multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538221
Neurology Kapoor R, Smith KE et. al.

Jul 17th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

Practical Sleep Information for People With Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.03.009
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.

May 13th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|

Immediate and Sustained Effects of Interventions for Changing Physical Activity in People with Multiple Sclerosis: Meta-Analysis of Randomized Controlled Trials
https://www.archives-pmr.org/article/S0003-9993(20)30217-3/pdf
Archives of Physical Medicine & Rehibilitation; Kim Y

Apr 24th, 2020 - To examine the immediate and sustained effects of interventions for changing physical activity behavior in people with multiple sclerosis (MS), and explore factors that might moderate intervention effects on physical activity behavior (e.g., inter...

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162735/
Neurol Sci.; Bonavita S

Apr 16th, 2020 - We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quick...

MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063292/
Quantitative Imaging in Medicine and Surgery; Barnett Y,et al

Feb 27th, 2020 - Over more than 35 years, advances in magnetic resonance imaging (MRI) techniques and analysis have fundamentally impacted both diagnostic criteria and treatment algorithms for multiple sclerosis (MS), a potentially disabling neurologic condition t...

see more →

Drugs  397 results see all →

Clinicaltrials.gov  57,257 results

Quality of life in multiple sclerosis is dominated by fatigue, disability and self-effi...
https://doi.org/10.1016/j.jns.2021.117437
Journal of the Neurological Sciences; Young CA, Mills R et. al.

May 15th, 2021 - Quality of life in multiple sclerosis (MS) reflects complex relationships between symptoms (fatigue, spasticity pain, and bladder or vision dysfunction), disability, health perceptions, and self-efficacy. In this cross-sectional study, a self-repo...

Identification of differential DNA methylation associated with multiple sclerosis: A fa...
https://doi.org/10.1016/j.jneuroim.2021.577600
Journal of Neuroimmunology; Garcia-Manteiga JM, Clarelli F et. al.

May 15th, 2021 - Multiple Sclerosis (MS) is caused by a still unknown interplay between genetic and environmental factors. Epigenetics, including DNA methylation, represents a model for environmental factors to influence MS risk. Twenty-six affected and 26 unaffec...

Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis.
https://doi.org/10.1097/WCO.0000000000000960
Current Opinion in Neurology; Hartung HP, Meuth SG et. al.

May 14th, 2021 - To assess the reasons for considering discontinuation of disease-modifying therapies (DMTs)in patients with multiple sclerosis (MS). Relevant aspects of the natural history, pathology, and immunology are analyzed. A number of retrospective observa...

Social cognition and executive functioning in multiple sclerosis: A cluster-analytic ap...
https://doi.org/10.1111/jnp.12248
Journal of Neuropsychology; Henry A, Lannoy S et. al.

May 14th, 2021 - Multiple sclerosis (MS) is associated with deficits in social cognition, the process underlying social interaction and cognitive function. However, the relationships between executive impairment and social cognition remain unclear in MS. Previous ...

Antinociceptive profile of ARN19702 (2-ethylsulfonylphenyl)-(2S)-4-(6-fluoro-1,3-benzot...
https://doi.org/10.1124/jpet.121.000674
The Journal of Pharmacology and Experimental Therapeutics; Fotio Y, Sasso O et. al.

May 14th, 2021 - N-acylethanolamine acid amidase (NAAA) is an N-terminal cysteine hydrolase that stops the physiological actions of palmitoylethanolamide (PEA), an endogenous lipid messenger that activates the transcription factor, peroxisome proliferator-activate...

see more →

News  4,975 results

Decreased COVID Antibody Response in MS Patients Taking Ocrelizumab
https://www.medscape.com/viewarticle/951052

May 12th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Dr Ilya Kister Antibody response is reduced in patients with multiple sclerosis (MS) who take a specific disease-modifying therapy (DMT) while inf...

Some MS Treatments May Heighten COVID Risk
https://www.medscape.com/viewarticle/950166

Apr 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. When it comes to SARS-CoV-2 infection among patients with multiple sclerosis (MS), disease-modifying therapies (DMTs) seem to have varying effects...

Investigational Drug Reduces Brain Lesions in Highly Active MS
https://www.medscape.com/viewarticle/949966

Apr 25th, 2021 - The investigational drug tolebrutinib effectively reduces brain lesions in patients with highly active relapsing-remitting multiple sclerosis (RRMS), new research suggests. After 12 weeks of treatment, MRI revealed the drug, a Bruton's tyrosine ki...

MRI Before Pregnancy Predicts Early Postpartum MS Relapse
https://www.medscape.com/viewarticle/949524

Apr 18th, 2021 - For women with multiple sclerosis (MS), results of MRI performed during the year before they become pregnant appear to accurately predict early relapse after childbirth, new research shows. Investigators found that women for whom there was evidenc...

Common MS Treatment Wears Off More Quickly in Black Patients
https://www.medscape.com/viewarticle/949488

Apr 16th, 2021 - Black patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) may respond differently to common MS treatment compared to their White peers, new research suggests. In a study of almost 200 patients, Black participant...

see more →

Patient Education  123 results see all →